10x Genomics Inc 's (TXG) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
10x Genomics Inc   (NASDAQ: TXG)
 



  10x Genomics Inc Outlook

On February 15 2024 the 10x Genomics Inc provided following guidance

10x Genomics Inc. announced its financial results for the fourth quarter and full year of 2023, with a revenue growth of 18% in the fourth quarter and 20% for the full year compared to the same periods in 2022. The company, known for its expertise in single cell and spatial biology, provided an optimistic outlook for 2024. The revenue growth demonstrates the company's continued success in the field of genomics and its commitment to innovation. Shareholders can expect further growth and development from 10x Genomics Inc. in the coming year.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.